| (TSX: IFC)
(in Canadian dollars except as otherwise noted) TORONTO, July 29, 2025 /CNW/ - Highlights - Operating DPW1,2 growth of 4% improved sequentially, primarily attributable to Personal lines
- Combined ratio1 was strong at 86.1% with solid performance across all geographies
- Net operating income per share1 of $5.23 (EPS of $4.70) reflected robust underwriting performance and stable contributions from investment and distribution income
- BVPS1 increased 12% from last year to $98.67 driven by solid earnings growth, with operating ROE1 of 16.3% (ROE1 of 14.0%)
- Robust balance sheet with total capital margin1 of $3.1 billion and adjusted debt-to-total capital ratio1 decreasing to 18.4%
Charles Brindamour, Chief Executive Officer, said: "I'm pleased to see our platform continuing to prove its strength in the current economic and geopolitical environment. We delivered another quarter of solid underlying results, while growing our premium base in Personal lines and remaining disciplined in Commercial and Specialty lines. We did not experience significant CAT losses in the quarter, but our business is well positioned to help our customers deal with the deep trend of increased natural disasters. With our resilient balance sheet, we remain ready to capture opportunities as they arise, while staying on track to continue delivering on our financial objectives of exceeding the industry ROE by 500 basis points and growing NOIPS by 10% annually over time." Consolidated Highlights
(in millions of Canadian dollars except as otherwise noted) | Q2-2025 | Q2-2024 | Change | H1-2025 | H1-2024 | Change | Operating direct premiums written1,2 | 7,031 | 6,655 | 4 % | 12,395 | 11,765 | 4 % | Combined ratio1 | 86.1 % | 87.1 % | (1.0) pt | 88.7 % | 89.1 % | (0.4) pts | Underwriting income (loss)1 | 784 | 681 | 15 % | 1,269 | 1,140 | 11 % | Operating net investment income | 400 | 387 | 3 % | 815 | 767 | 6 % | Distribution income1 | 165 | 169 | (2) % | 282 | 269 | 5 % | Net operating income attributable to common shareholders1 | 935 | 866 | 8 % | 1,652 | 1,513 | 9 % | Net income | 867 | 758 | 14 % | 1,543 | 1,431 | 8 % | Per share measures (in dollars) |
|
|
|
|
|
| Net operating income per share (NOIPS)1,3 | $5.23 | $4.86 | 8 % | $9.25 | $8.48 | 9 % | Earnings per share (EPS) – diluted3 | $4.70 | $4.04 | 16 % | $8.39 | $7.72 | 9 % | Book value per share1 | $98.67 | $88.00 | 12 % |
|
|
| Return on equity for the last 12 months |
|
|
|
|
|
| Operating ROE1 | 16.3 % | 17.0 % | (0.7) pts |
|
|
| Adjusted ROE1 | 16.5 % | 16.7 % | (0.2) pts |
|
|
| ROE1 | 14.0 % | 13.7 % | 0.3 pts |
|
|
| Capital management |
|
|
|
|
|
| Total capital margin1 | $3,136 | 2,884 | 252 |
|
|
| Adjusted debt-to-total capital ratio1 | 18.4 % | 19.8 % | (1.4) pts |
|
|
|
12-Month Industry Outlook We expect favourable market conditions overall, though varying by segment: - In Personal auto and Personal property, we expect high-single-digit to low-double-digit premium growth; and
- In Commercial and Specialty lines across all geographies, we expect mid-single-digit premium growth.
____________________________________________ | 1 | This release contains Non-GAAP financial measures, Non-GAAP ratios and other financial measures (each as defined in National Instrument 52-112 "Non-GAAP and Other Financial Measures Disclosure"). Refer to Section 15 – Non-GAAP and other financial measures in the Q2-2025 Management's Discussion and Analysis for further details. | 2 | DPW change (growth) is presented in constant currency. | 3 | Per share metric is calculated based on the weighted-average diluted number of common shares. |
Q2-2025 Consolidated Performance - Operating DPW growth was 4%, attributable to rate actions and continued unit growth in Personal lines. Within Commercial lines, growth was tempered by continued pressures in large accounts, as well as remediation actions in the UK&I.
- Combined ratio remained strong and improved by 1 point to 86.1%, despite higher catastrophe activity compared to last year's low level. This reflected solid performance across all geographies, as well as strong favourable prior year development, notably in Canada Commercial lines.
- Operating net investment income increased 3% from last year to $400 million, due to slightly higher book yields and favourable foreign currency movements.
- Distribution income of $165 million reflected solid M&A activities in BrokerLink, offset by slower growth in other parts of the business, including On Side.
- Net operating income attributable to common shareholders of $935 million reflected strong underwriting performance, as well as stable contributions from investment and distribution income.
- Earnings per share increased 16% to $4.70 in the quarter, driven by strong operating income and higher mark-to-market gains on our equity securities.
- Solid operating ROE of 16.3% reflected a robust performance across our lines of business and geographies, despite the impact of higher-than-expected catastrophe losses over the last 12 months. Adjusted ROE of 16.5% included lower exited lines losses and restructuring costs over the last 12 months.
Segment Underwriting Performance (in millions of Canadian dollars except as otherwise noted) | Q2 2025 | Q2 2024 | Change | H1-2025 | H1-2024 | Change | Operating direct premiums written 1 (growth in constant currency) |
|
|
|
| Canada | 4,908 | 4,563 | 8 % | 8,388 | 7,815 | 7 % | UK&I | 1,330 | 1,315 | (5) % | 2,583 | 2,560 | (5) % | US | 793 | 777 | - % | 1,424 | 1,390 | (1) % | Total | 7,031 | 6,655 | 4 % | 12,395 | 11,765 | 4 % | Combined ratio1 |
|
|
|
|
|
| Canada | 83.8 % | 85.4 % | (1.6) pts | 87.0 % | 88.1 % | (1.1) pts | UK&I | 92.9 % | 92.2 % | 0.7 pts | 95.2 % | 93.4 % | 1.8 pts | US | 87.8 % | 88.5 % | (0.7) pts | 87.2 % | 88.3 % | (1.1) pts | Combined ratio | 86.1 % | 87.1 % | (1.0) pt | 88.7 % | 89.1 % | (0.4) pts |
|
|
|
|
|
|
|
|
|
|
|
Canada - Personal auto operating DPW increased by 11%, reflecting rate actions and 2% unit growth in hard market conditions. The combined ratio was strong at 90.3% in a seasonally favourable quarter, reflecting the benefits of our profitability actions.
- Personal property operating DPW grew by 10%, primarily due to rates and 2% unit growth in hard market conditions. The combined ratio remained strong at 84.5% despite increasing 6.5 points from last year, as the prior period benefitted from benign weather activity.
- Commercial lines operating DPW growth was 1%, driven by low-to-mid-single-digit rates overall. We continue to see elevated competition in large accounts. The combined ratio was very strong at 74.0%, driven by our continued underwriting discipline and very healthy favourable prior-year development.
UK&I - Operating DPW decreased 5% reflecting continued remediation actions in the DLG portfolio, as well as strategic exits, primarily within certain delegated relationships. Excluding these items, growth was 3% as we continue to see competition in large accounts. The combined ratio of 92.9% remained solid despite higher large losses, reflecting performance improvements in the DLG portfolio.
US - Operating DPW growth was flat, including a 3-point negative impact from a specific business line. Rates remained healthy overall. The combined ratio was solid at 87.8%, reflecting year-over-year improvements in our underlying performance, tempered by higher expenses.
___________________________________________ | 1 This release contains Non-GAAP financial measures, Non-GAAP ratios and other financial measures (each as defined in National Instrument 52-112 "Non-GAAP and Other Financial Measures Disclosure"). Refer to Section 15 – Non-GAAP and other financial measures in the Q2-2025 Management's Discussion and Analysis for further details. |
Balance Sheet - The Company ended the quarter in a strong financial position and solid regulatory capital ratios in all jurisdictions. Total capital margin was $3.1 billion, and in line with Q1-2025, due to strong operating earnings.
- Adjusted debt-to-total capital ratio stood at 18.4% as at June 30, 2025, a reduction vs. Q1-2025, driven by strong capital generation and the repayment of commercial paper in the quarter.
- IFC's book value per share (BVPS) of $98.67 as at June 30, 2025 increased 12% year-over-year due to robust earnings over the last 12 months and favourable market movements. BVPS was 3% higher than Q1-2025, driven by strong operating earnings, tempered by foreign exchange impacts.
Common Share Dividend - The Board of Directors approved the quarterly dividend of $1.33 per share on the Company's outstanding common shares. The common share dividends are payable on September 29, 2025, to shareholders of record on September 15, 2025.
Preferred Share Dividends - The Board of Directors also approved a quarterly dividend of 30.25625 cents per share on the Company's Class A Series 1 preferred shares, 21.60625 cents per share on the Class A Series 3 preferred shares, 32.5 cents per share on the Class A Series 5 preferred shares, 33.125 cents per share on the Class A Series 6 preferred shares, 37.575 cents per share on the Class A Series 7 preferred shares, 33.75 cents per share on the Class A Series 9 preferred shares, and 32.8125 cents per share on the Class A Series 11 preferred shares. The dividends are payable on September 30, 2025, to shareholders of record on September 15, 2025.
Analysts' Estimates - The average estimate of earnings per share and net operating income per share for the quarter among the analysts who follow the Company was $3.79 and $4.02, respectively.
Management's Discussion and Analysis (MD&A) and Interim Consolidated Financial Statements This Press Release, which was approved by the Company's Board of Directors on the Audit Committee's recommendation, should be read in conjunction with the Q2-2025 MD&A, as well as the Q2-2025 interim condensed consolidated financial statements, which are available on the Company's website at www.intactfc.com and later today on SEDAR+ at www.sedarplus.ca. For the definitions of measures and other insurance-related terms used in this Press Release, please refer to the MD&A and to the glossary available in the "Investors" section of the Company's website at www.intactfc.com. Conference Call Details Intact Financial Corporation will host a conference call to review its earnings results tomorrow at 11:00 a.m. ET. To listen to the call via live audio webcast and to view the Company's interim condensed consolidated financial statements, MD&A, presentation slides, Supplementary financial information and other information not included in this Press Release, visit the Company's website at www.intactfc.com and link to "Investors". The conference call is also available by dialing 416-945-7677 or 1-888-699-1199 (toll-free in North America). Please call 10 minutes before the start of the call. A replay of the call will be available on July 30, 2025 at 2:00 p.m. ET until 11:59 p.m. ET on August 6, 2025. To listen to the replay, call 289-819-1450 or 1-888-660-6345 (toll-free in North America), entry code 88467. A transcript of the call will also be made available on Intact Financial Corporation's website. About Intact Financial Corporation Intact Financial Corporation (TSX: IFC) is the largest provider of Property and Casualty (P&C) insurance in Canada, a leading Specialty lines insurer with international expertise and a leader in Commercial lines in the UK and Ireland. The business has grown organically and through acquisitions to almost $24 billion of total annual operating direct premiums written (DPW). In Canada, Intact distributes insurance under the Intact Insurance brand through agencies and a wide network of brokers, including its wholly- owned subsidiary BrokerLink. Intact also distributes directly to consumers through the belairdirect brand and affinity partnerships. Additionally, Intact provides exclusive and tailored offerings to high-net-worth customers through Intact Prestige. In the US, Intact Insurance Specialty Solutions provides a range of Specialty insurance products and services through independent agencies, regional and national brokers, wholesalers and managing general agencies. Across the UK, Ireland, and Europe, Intact provides Personal, Commercial and/or Specialty insurance solutions through the RSA, 123.ie, NIG and FarmWeb brands. Non-GAAP and other financial measures Non-GAAP financial measures and Non-GAAP ratios (which are calculated using Non-GAAP financial measures) do not have standardized meanings prescribed by IFRS (or GAAP) and may not be comparable to similar measures used by other companies in our industry. Non-GAAP and other financial measures are used by management and financial analysts to assess our performance. Further, they provide users with an enhanced understanding of our financial results and related trends, and increase transparency and clarity into the core results of the business. Non-GAAP financial measures and Non-GAAP ratios used in this Press Release and other Company's financial reports include measures related to our consolidated performance, underwriting performance and financial strength. For more information about these supplementary financial measures, Non-GAAP financial measures, and Non-GAAP ratios, including definitions and explanations of how these measures provide useful information, refer to Section 15 – Non-GAAP and other financial measures in the Q2-2025 MD&A dated July 29th, 2025, which is available on our website at www.intactfc.com and on SEDAR+ at www.sedarplus.ca. Table 1 Reconciliation of NOI, NOIPS and OROE to Net income attributable to shareholders
| Q2-2025 | Q2-2024 | H1-2025 | H1-2024 |
|
|
|
|
| Net income attributable to shareholders, as reported under IFRS | 867 | 750 | 1,543 | 1,423 | Remove: pre-tax non-operating results | 93 | 128 | 167 | 140 | Remove: non-operating tax expense (benefit) | 3 | 16 | (13) | (5) | N OI attributable to shareholders | 963 | 894 | 1,697 | 1,558 | Remove: preferred share dividends and other equity distribution | (28) | (28) | (45) | (45) | NOI attributable to common shareholders | 935 | 866 | 1,652 | 1,513 | Divided by weighted-average diluted number of common shares (in millions) | 178.7 | 178.5 | 178.7 | 178.5 | NOIPS (in dollars) | 5.23 | 4.86 | 9.25 | 8.48 | NOI attributable to common shareholders for the last 12 months | 2,715 | 2,575 |
|
| Adjusted average common shareholders' equity, excluding AOCI | 16,636 | 15,151 |
|
| OROE for the last 12 months | 16.3 % | 17.0 % |
|
|
Table 2 Reconciliation of underwriting results on a MD&A basis with the interim consolidated financial statements (quarterly) Financial statements | F/S | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Total | MD&A | MD&A | Quarter endedJune 30, 2025 |
| Insurance revenue | 6,616 | (598) | (225) | - | - | - | - | (111) | (57) | 5 | (986) | 5,630 | Operating net underwriting revenue | Insurance service expense | (5,083) | 257 | 232 | (150) | 7 | (58) | (215) | 112 | 57 | (5) | 237 | (4,846) | Sum of: Operating net claims
($2,917 million) and Operating net
underwriting expenses ($1,929
million) | Expense from reinsurance contracts | (598) | 598 | - | - | - | - | - | - | - | - | 598 | - | n/a | Income from reinsurance contracts | 257 | (257) | - | - | - | - | - | - | - | - | (257) | - | n/a | Insurance service result | 1,192 | - | 7 | (150) | 7 | (58) | (215) | 1 | - | - | (408) | 784 | Underwriting income (loss) | Quarter endedJune 30, 2024 |
| Insurance revenue | 6,488 | (619) | (356) | - | - | - | - | (207) | (12) | 7 | (1,187) | 5,301 | Operating net underwriting revenue | Insurance service expense | (5,196) | 365 | 370 | (114) | 8 | (44) | (237) | 223 | 12 | (7) | 576 | (4,620) | Sum of: Operating net claims
($2,812 million) and Operating net
underwriting expenses ($1,808
million) | Expense from reinsurance contracts | (619) | 619 | - | - | - | - | - | - | - | - | 619 | - | n/a | Income from reinsurance contracts | 365 | (365) | - | - | - | - | - | - | - | - | (365) | - | n/a | Insurance service result | 1,038 | - | 14 | (114) | 8 | (44) | (237) | 16 | - | - | (357) | 681 | Underwriting income (loss) |
Reconciling items in the table above: 1 | Adjustment to present results net of reinsurance | 2 | Adjustment to exclude net underwriting revenue, net claims, net underwriting expenses from exited lines (treated as non-operating) | 3 | Adjustment to include indirect underwriting expenses (from Other income and expense under IFRS) | 4 | Adjustment to exclude the non-operating pension expense | 5 | Adjustment to reclassify intercompany commissions (to Distribution income & Other operating income (expense)) | 6 | Adjustment to exclude discount build on claims liabilities (treated as non-operating) | 7 | Adjustment to exclude Net insurance service results from claims acquired in a business combination (treated as non-operating) | 8 | Adjustment to reclassify Assumed (ceded) commissions and premium adjustments | 9 | Adjustment to reclassify Net insurance revenue from retroactive reinsurance contracts |
Table 3 Reconciliation of underwriting results on a MD&A basis with the interim consolidated financial statements (year-to-date) Financial statements | F/S | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Total | MD&A | MD&A | Six-month endedJune 30, 2025 |
| Insurance revenue | 13,269 | (1,196) | (502) | - | - | - | - | (308) | (105) | 26 | (2,085) | 11,184 | Operating net underwriting
revenue | Insurance service expense | (10,670) | 650 | 514 | (269) | 15 | (120) | (433) | 319 | 105 | (26) | 755 | (9,915) | Sum of: Operating net claims
($6,125 million) and Operating
net underwriting expenses
($3,790 million) | Expense from reinsurance contracts | (1,196) | 1,196 | - | - | - | - | - | - | - | - | 1,196 | - | n/a | Income from reinsurance contracts | 650 | (650) | - | - | - | - | - | - | - | - | (650) | - | n/a | Insurance service result | 2,053 | - | 12 | (269) | 15 | (120) | (433) | 11 | - | - | (784) | 1,269 | Underwriting income (loss) | Six-month endedJune 30, 2024 |
| Insurance revenue | 12,999 | (1,292) | (715) | - | - | - | - | (488) | (32) | 22 | (2,505) | 10,494 | Operating net underwriting
revenue | Insurance service expense | (10,554) | 679 | 790 | (262) | 16 | (93) | (465) | 525 | 32 | (22) | 1,200 | (9,354) | Sum of: Operating net claims
($5,757 million) and Operating
net underwriting expenses
($3,597 million) | Expense from reinsurance contracts | (1,292) | 1,292 | - | - | - | - | - | - | - | - | 1,292 | - | n/a | Income from reinsurance contracts | 679 | (679) | - | - | - | - | - | - | - | - | (679) | - | n/a | Insurance service result | 1,832 | - | 75 | (262) | 16 | (93) | (465) | 37 | - | - | (692) | 1,140 | Underwriting income (loss) |
Reconciling items in the table above: 1 | Adjustment to present results net of reinsurance | 2 | Adjustment to exclude net underwriting revenue, net claims, net underwriting expenses from exited lines (treated as non-operating) | 3 | Adjustment to include indirect underwriting expenses (from Other income and expense under IFRS) | 4 | Adjustment to exclude the non-operating pension expense | 5 | Adjustment to reclassify intercompany commissions (to Distribution income & Other operating income (expense)) | 6 | Adjustment to exclude discount build on claims liabilities (treated as non-operating) | 7 | Adjustment to exclude Net insurance service results from claims acquired in a business combination (treated as non-operating) | 8 | Adjustment to reclassify Assumed (ceded) commissions and premium adjustments | 9 | Adjustment to reclassify Net insurance revenue from retroactive reinsurance contracts |
Table 4 Reconciliation of ROE to Net income attributable to shareholders
| Q2-2025 | Q2-2024 | H1-2025 | H1-2024 | Net income attributable to shareholders, as reported under IFRS | 867 | 750 | 1,543 | 1,423 | Remove: preferred share dividends and other equity distribution | (28) | (28) | (45) | (45) | Net income attributable to common shareholders | 839 | 722 | 1,498 | 1,378 | Divided by weighted-average basic number of common shares (in millions) | 178.3 | 178.3 | 178.3 | 178.3 | EPS, basic (in dollars) | 4.71 | 4.05 | 8.40 | 7.73 |
|
|
|
|
| Divided by weighted-average diluted number of common shares1 (in millions) | 178.7 | 178.5 | 178.7 | 178.5 | EPS, diluted (in dollars) | 4.70 | 4.04 | 8.39 | 7.72 | Net income attributable to common shareholders for the last 12 months | 2,327 | 2,020 |
|
| Adjusted average common shareholders' equity | 16,647 | 14,698 |
|
| ROE for the last 12 months | 14.0 % | 13.7 % |
|
|
1 Includes the net effect of the exercise of stock options. See Note 16 – Earnings per share to the interim condensed consolidated financial statements for more details. |
Table 5 Reconciliation of consolidated results on a MD&A basis with the interim condensed consolidated financial statements (quarterly)
| MD&A captions | Pre-tax | As presented in the Financial statements | Distribution
income | Total
finance
costs | Other
operating
income
(expense) | Operating net
investment
income | Total
income
taxes | Non-
operating
results | Underwriting
income
(loss) | Total F/S
caption | For the quarter ended June 30, 2025 | Insurance service result | 43 | - | 15 | - | - | 200 | 934 | 1,192 | Net investment income | - | - | - | 400 | - | - | - | 400 | Net gains (losses) on investment portfolio | - | - | - | - | - | 136 | - | 136 | Net insurance financial result | - | - | - | - | - | (197) | - | (197) | Share of profits from investments in associates
and joint ventures | 42 | (4) | (2) | - | (9) | (9) | - | 18 | Other net gains (losses) | - | - | - | - | - | (16) | - | (16) | Other income and expense | 80 | - | (65) | - | - | (80) | (150) | (215) | Other finance costs | - | (57) | - | - | - | - | - | (57) | Acquisition, integration and restructuring costs | - | - | - | - | - | (127) | - | (127) | Income tax benefit (expense) | - | - | - | - | (267) | - | - | (267) |
|
|
|
|
|
|
|
|
| Total, as reported in MD&A | 165 | (61) | (52) | 400 | (276) | (93) | 784 |
| For the quarter ended June 30, 2024 | Insurance service result | 28 | - | 16 | - | - | 199 | 795 | 1,038 | Net investment income | - | - | - | 387 | - | - | - | 387 | Net gains (losses) on investment portfolio | - | - | - | - | - | (34) | - | (34) | Net insurance financial result | - | - | - | - | - | (195) | - | (195) | Share of profits from investments in associates
and joint ventures | 52 | (3) | (1) | - | (11) | (9) | - | 28 | Other net gains (losses) | - | - | - | - | - | 74 | - | 74 | Other income and expense | 89 | - | (75) | - | - | (73) | (114) | (173) | Other finance costs | - | (54) | - | - | - | - | - | (54) | Acquisition, integration and restructuring costs | - | - | - | - | - | (90) | - | (90) | Income tax benefit (expense) | - | - | - | - | (223) | - | - | (223) | Total, as reported in MD&A | 169 | (57) | (60) | 387 | (234) | (128) | 681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 6 Reconciliation of consolidated results on a MD&A basis with the interim condensed consolidated financial statements (year-to-date)
| MD&A captions | Pre-tax | As presented in the Financial statements | Distribution
income | Total
finance
costs | Other
operating
income
(expense) | Operating net
investment
income | Total
income
taxes | Non-
operating
results | Underwriting
income
(loss) | Total F/S
caption | For the six-month period ended June 30, 2025 | Insurance service result | 108 | - | 12 | - | - | 395 | 1,538 | 2,053 | Net investment income | - | - | - | 815 | - | - | - | 815 | Net gains (losses) on investment portfolio | - | - | - | - | - | 222 | - | 222 | Net insurance financial result | - | - | - | - | - | (437) | - | (437) | Share of profits from investments in associates
and joint ventures | 84 | (7) | (1) | - | (18) | (18) | - | 40 | Other net gains (losses) | - | - | - | - | - | 24 | - | 24 | Other income and expense | 90 | - | (90) | - | - | (157) | (269) | (426) | Other finance costs | - | (112) | - | - | - | - | - | (112) | Acquisition, integration and restructuring costs | - | - | - | - | - | (196) | - | (196) | Income tax benefit (expense) | - | - | - | - | (440) | - | - | (440) |
|
|
|
|
|
|
|
|
| Total, as reported in MD&A | 282 | (119) | (79) | 815 | (458) | (167) | 1,269 |
| For the six-month period ended June 30, 2024 | Insurance service result | 71 | - | 22 | - | - | 337 | 1,402 | 1,832 | Net investment income | - | - | - | 767 | - | - | - | 767 | Net gains (losses) on investment portfolio | - | - | - | - | - | (74) | - | (74) | Net insurance financial result | - | - | - | - | - | (292) | - | (292) | Share of profits from investments in associates
and joint ventures | 90 | (8) | 1 | - | (18) | (15) | - | 50 | Other net gains (losses) | - | - | - | - | - | 254 | - | 254 | Other income and expense | 108 | - | (111) | - | - | (147) | (262) | (412) | Other finance costs | - | (111) | - | - | - | - | - | (111) | Acquisition, integration and restructuring costs | - | - | - | - | - | (203) | - | (203) | Income tax benefit (expense) | - | - | - | - | (380) | - | - | (380) | Total, as reported in MD&A | 269 | (119) | (88) | 767 | (398) | (140) | 1,140 |
|
|
Table 7 Reconciliation of AEPS and AROE to Net income attributable to shareholders
| Q2-2025 | Q2-2024 | H1-2025 | H1-2024 | Net income attributable to shareholders, as reported under IFRS | 867 | 750 | 1,543 | 1,423 | Remove acquisition-related items, after tax |
|
|
|
| Amortization of acquired intangible assets | 61 | 56 | 122 | 113 | Acquisition and integration costs | 56 | 41 | 86 | 96 | Tax adjustments on acquisition-related items | 7 | 3 | 8 | 3 | Net result from claims acquired in a business combination | 1 | (1) | 1 | 1 | Adjusted net income attributable to shareholders | 992 | 849 | 1,760 | 1,636 | Remove: preferred share dividends and other equity distribution | (28) | (28) | (45) | (45) | Adjusted net income attributable to common shareholders | 964 | 821 | 1,715 | 1,591 | Divided by weighted-average diluted number of common shares (in millions) | 178.7 | 178.5 | 178.7 | 178.5 | AEPS (in dollars) | 5.39 | 4.61 | 9.59 | 8.91 | Adjusted net income attributable to common shareholders for the last 12 months | 2,744 | 2,453 |
|
| Adjusted average common shareholders' equity | 16,647 | 14,698 |
|
| AROE for the last 12 months | 16.5 % | 16.7 % |
|
|
Table 8 Calculation of BVPS and BVPS (excluding AOCI) As at June 30, | 2025 | 2024 |
|
|
| Equity attributable to shareholders, as reported under IFRS | 19,216 | 17,315 | Remove: Preferred shares and other equity, as reported under IFRS | (1,619) | (1,619) |
|
|
| Common shareholders' equity | 17,597 | 15,696 | Remove: AOCI, as reported under IFRS | (260) | 238 |
|
|
| Common shareholders' equity (excluding AOCI) | 17,337 | 15,934 | Number of common shares outstanding at the same date (in millions) | 178.3 | 178.4 | BVPS | 98.67 | 88.00 | BVPS (excluding AOCI) | 97.21 | 89.33 |
Table 9 Adjusted average common shareholders' equity and Adjusted average common shareholders' equity, excluding AOCI As at June 30, | 2025 | 2024 |
|
|
| Ending common shareholders' equity | 17,597 | 15,696 | Remove: significant capital transaction in the last 12 months | - | (557) | Ending common shareholders' equity, excluding significant capital transaction | 17,597 | 15,139 | Beginning common shareholders' equity | 15,696 | 13,370 | Average common shareholders' equity, excluding significant capital transaction | 16,647 | 14,255 | Weighted impact of significant capital transactions1 | - | 443 | Adjusted average common shareholders' equity | 16,647 | 14,698 |
|
|
| Ending common shareholders' equity, excluding AOCI | 17,337 | 15,934 | Remove: significant capital transaction in the last 12 months | - | (557) | Ending common shareholders' equity, excluding AOCI and significant capital transaction | 17,337 | 15,377 | Beginning common shareholders' equity, excluding AOCI | 15,934 | 14,040 | Average common shareholders' equity, excluding AOCI and significant capital transaction | 16,636 | 14,708 | Weighted impact of significant capital transactions1 | - | 443 | Adjusted average common shareholders' equity, excluding AOCI | 16,636 | 15,151 |
1 June 30, 2024 figure represents the net weighted impact of the September 13, 2023 significant capital transaction. |
Table 10 Reconciliation of Total debt outstanding before hybrid subordinated notes and Total capital to Debt outstanding, Equity attributable to shareholders and Equity attributable to NCI As at | June 30, 2025 | March 31, 2025 | December 31, 2024 |
|
|
|
| Debt outstanding, as reported under IFRS | 4,643 | 4,728 | 4,681 | Remove: hybrid subordinated notes | (247) | (247) | (247) | Total debt outstanding before hybrid subordinated notes | 4,396 | 4,481 | 4,434 |
|
|
|
| Debt outstanding, as reported under IFRS | 4,643 | 4,728 | 4,681 | Equity attributable to shareholders, as reported under IFRS | 19,216 | 18,768 | 18,148 | Adjusted total capital | 23,859 | 23,496 | 22,829 |
|
|
|
| Total debt outstanding before hybrid subordinated notes | 4,396 | 4,481 | 4,434 | Adjusted total capital | 23,859 | 23,496 | 22,829 | Adjusted debt-to-total capital ratio | 18.4 % | 19.1 % | 19.4 % |
|
|
|
| Debt outstanding, as reported under IFRS | 4,643 | 4,728 | 4,681 | Preferred shares and other equity, as reported under IFRS | 1,619 | 1,619 | 1,619 | Debt outstanding and preferred shares (including NCI) | 6,262 | 6,347 | 6,300 | Adjusted total capital | 23,859 | 23,496 | 22,829 | Total leverage ratio | 26.2 % | 27.0 % | 27.6 % | Adjusted debt-to-total capital ratio | 18.4 % | 19.1 % | 19.4 % | Preferred shares and hybrids | 7.8 % | 7.9 % | 8.2 % |
Forward Looking Statements Certain statements made in this news release are forward-looking statements. These statements include, without limitation, statements relating to the outlook for the Property and Casualty insurance industry in Canada, the U.S. and the U.K., the Company's business outlook, the Company's growth prospects and the integration of Direct Line Insurance Group plc's brokered Commercial lines operations. All such forward-looking statements are made pursuant to the 'safe harbour' provisions of applicable Canadian securities laws. Forward-looking statements, by their very nature, are subject to inherent risks and uncertainties and are based on several assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements as a result of various factors, including those discussed in the Company's most recently filed Annual Information Form dated February 11, 2025 and available on SEDAR+ at www.sedarplus.ca. As a result, we cannot guarantee that any forward-looking statement will materialize and we caution you against relying on any of these forward-looking statements. Except as may be required by Canadian securities laws, we do not undertake any obligation to update or revise any forward-looking statements contained in this news release, whether as a result of new information, future events or otherwise. Please read the cautionary note at the beginning of the Q2-2025 MD&A. SOURCE Intact Financial Corporation | |
